Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

The role of stress-response systems for the pathogenesis and progression of MS.

Gold SM, Mohr DC, Huitinga I, Flachenecker P, Sternberg EM, Heesen C.

Trends Immunol. 2005 Dec;26(12):644-52. Epub 2005 Oct 7. Review.

PMID:
16214415
2.

Stress and disease progression in multiple sclerosis and its animal models.

Gold SM, Heesen C.

Neuroimmunomodulation. 2006;13(5-6):318-26. Epub 2007 Aug 6.

PMID:
17709954
3.

Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review.

Heesen C, Gold SM, Huitinga I, Reul JM.

Psychoneuroendocrinology. 2007 Jul;32(6):604-18. Epub 2007 Jun 29. Review.

PMID:
17602841
4.

Neurodegeneration in autoimmune CNS inflammation.

Herz J, Zipp F, Siffrin V.

Exp Neurol. 2010 Sep;225(1):9-17. doi: 10.1016/j.expneurol.2009.11.019. Epub 2009 Dec 1. Review.

PMID:
19961850
5.

Disease progression in chronic relapsing experimental allergic encephalomyelitis is associated with reduced inflammation-driven production of corticosterone.

Stefferl A, Storch MK, Linington C, Stadelmann C, Lassmann H, Pohl T, Holsboer F, Tilders FJ, Reul JM.

Endocrinology. 2001 Aug;142(8):3616-24.

PMID:
11459810
6.

Experimental models of multiple sclerosis.

Pachner AR.

Curr Opin Neurol. 2011 Jun;24(3):291-9. doi: 10.1097/WCO.0b013e328346c226. Review.

PMID:
21519255
7.

Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.

Rostami A, Ciric B.

J Neurol Sci. 2013 Oct 15;333(1-2):76-87. doi: 10.1016/j.jns.2013.03.002. Epub 2013 Apr 8. Review.

8.

Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis.

Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, Trapp BD.

J Neuropathol Exp Neurol. 2002 Jan;61(1):23-32.

PMID:
11829341
9.

A little stress is good: IFN-gamma, demyelination, and multiple sclerosis.

Lees JR, Cross AH.

J Clin Invest. 2007 Feb;117(2):297-9.

10.

In vitro and in vivo models of multiple sclerosis.

van der Star BJ, Vogel DY, Kipp M, Puentes F, Baker D, Amor S.

CNS Neurol Disord Drug Targets. 2012 Aug;11(5):570-88. Review.

PMID:
22583443
11.

Stress, glucocorticoids and the susceptibility to develop autoimmune disorders of the central nervous system.

Morale C, Brouwer J, Testa N, Tirolo C, Barden N, Dijkstra CD, Amor S, Marchetti B.

Neurol Sci. 2001 Apr;22(2):159-62.

PMID:
11603619
12.

New findings and old controversies in the research of multiple sclerosis and its model experimental autoimmune encephalomyelitis.

Aharoni R.

Expert Rev Clin Immunol. 2013 May;9(5):423-40. doi: 10.1586/eci.13.21. Review.

PMID:
23634737
13.

New immunopathologic insights into multiple sclerosis.

Hemmer B, Kieseier B, Cepok S, Hartung HP.

Curr Neurol Neurosci Rep. 2003 May;3(3):246-55. Review.

PMID:
12691630
14.

The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation.

Zozulya AL, Wiendl H.

Hum Immunol. 2008 Nov;69(11):797-804. doi: 10.1016/j.humimm.2008.07.014. Epub 2008 Aug 22. Review.

PMID:
18723060
15.

Pathogenesis of multiple sclerosis: an update on immunology.

Hemmer B, Cepok S, Nessler S, Sommer N.

Curr Opin Neurol. 2002 Jun;15(3):227-31. Review.

PMID:
12045717
16.

[Experimental autoimmune encephalomyelitis].

Cornet A, Vizler C, Liblau R.

Rev Neurol (Paris). 1998 Sep;154(8-9):586-91. Review. French.

PMID:
9809373
17.
18.

Animal models of multiple sclerosis: the good, the bad and the bottom line.

Ransohoff RM.

Nat Neurosci. 2012 Jul 26;15(8):1074-7. doi: 10.1038/nn.3168.

PMID:
22837037
19.

The hypothalamo-pituitary-adrenal axis in multiple sclerosis.

Huitinga I, Erkut ZA, van Beurden D, Swaab DF.

Ann N Y Acad Sci. 2003 May;992:118-28. Review.

PMID:
12794052
20.

Pathogenesis of multiple sclerosis.

Prat A, Antel J.

Curr Opin Neurol. 2005 Jun;18(3):225-30. Review.

PMID:
15891404

Supplemental Content

Support Center